Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green River Polymers is a sustainable materials and biotechnology company specializing in the development of bio-based, non-toxic polymer technologies. Founded as a spin-off from the University of Massachusetts Lowell, the company utilizes a proprietary enzymatic synthesis platform to create functional polymers from renewable feedstocks such as vegetable oils and lignin. Their technology focuses on replacing hazardous chemicals and petroleum-derived materials in applications such as biocompatible coatings, drug delivery systems, and non-toxic flame retardants. By leveraging green chemistry principles, Green River Polymers provides environmentally friendly solutions for the healthcare, personal care, and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green River Polymers.